Annual Report 2015 Smiths Group Plc

Total Page:16

File Type:pdf, Size:1020Kb

Annual Report 2015 Smiths Group Plc Annual Report 2015 Smiths Group plc Bringing technology to life Highlights EPS up 5% and continued strong headline operating Revenue cash conversion at 95%, despite revenue decline of 2% £m £2,897m down 2% Smiths Medical delivers highest revenue growth in almost a decade 2015 2,897 2014 2,952 John Crane aftermarket strength underpins 2013 3,109 resilient performance 2012 3,038 2011 2,842 Smiths Detection reports margin improvement Read more on page 23 and strong order book and note 1 Difficult trading conditions at Smiths Interconnect Headline operating profit Continued solid performance from Flex-Tek £m £511m up 1% Increased investment in growth initiatives through Engineered for Growth programme 2015 511 2014 504 Net accounting pension deficit reduced to £108m 2013 560 – its lowest reported level since 2008 2012 554 2011 517 Read more on pages 23, 174 Continuing activities and note 1 2015 2014 £m £m Free cash-flow Revenue 2,897 2,952 £m Headline operating profit 511 504 Statutory operating profit 394 378 £158m up 10% Headline basic EPS 86.1p 81.8p Statutory basic EPS 62.4p 59.0p 2015 158 Free cash-flow 158 143 2014 143 Dividend 41.00p 40.25p 2013 237 Return on capital employed 16.0% 15.7% 2012 217 Headline profit is before exceptional items, amortisation and impairment of acquired intangible assets, pension 2011 236 charges and financing gains/losses from currency hedging. Free cash-flow and return on capital employed are described in the Financial review. Read more on pages 54, 174 and note 27 Underlying performance is organic growth adjusting for foreign exchange translation. Headline earnings per share Pence 86.1p up 5% 2015 86.1 2014 81.8 2013 92.7 2012 92.6 2011 86.5 Read more on pages 54, 174 and note 6 Read more at www.smiths.com The purpose of this document is to provide information to the members of the Company. This document contains certain statements that are forward-looking statements. They appear in a number of places throughout this document and include statements regarding our intentions, beliefs or current expectations and those of our officers, directors and employees concerning, amongst other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the business we operate. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of this document and unless otherwise required by applicable law the Company undertakes no obligation to update or revise these forward-looking statements. Nothing in this document should be construed as a profit forecast. The Company and its directors accept no liability to third parties in respect of this document save as would arise under English law. This report contains brands that are trademarks and are registered and/or otherwise protected in accordance with applicable law. Contents Strategic report Governance Accounts Strategic overview We introduce our Board, explain our This section contains the financial We explain who we are, where we operate, approach to corporate governance and give statements, the auditors’ report, our business model and strategy, investment details of the Company’s remuneration the accounting policies and the notes case and a summary of how we performed principles and policies to support to the accounts against our key performance indicators shareholder value creation Statement of directors’ Bringing technology to life 4 Board of directors 74 responsibilities 120 Who we are 8 Corporate governance statement 77 Independent auditors’ report to the members of Smiths Group plc Our geographic reach 9 Directors’ remuneration report 94 – Group 121 Our divisions 10 Group directors’ report 112 overview – Strategic report Strategic Consolidated income statement 127 Chairman’s statement 12 Consolidated statement Chief Executive’s statement 14 of comprehensive income 128 Our markets 17 Consolidated balance sheet 129 Our business model 18 Consolidated statement of changes in equity 130 Our strategy and progress 20 Consolidated cash-flow statement 131 The investment case 22 Accounting policies 132 Operational review Notes to the accounts 138 For the Group and each division, we review our markets and trends, Unaudited Group financial record review – Operational report Strategic key operational developments during the 2011-2015 174 year and future outlook. We also review Unaudited US dollar primary our financial performance statements 175 Group 23 Independent auditors’ report to the members of Smiths Group plc John Crane 24 – Parent company 180 Smiths Medical 30 Smiths Group plc company accounts 182 Smiths Detection 36 Financial calendar 194 Smiths Interconnect 42 Flex-Tek 48 Financial review 54 and responsibility – Risks report Strategic Litigation 57 Risks and responsibility We set out the key risks that may affect our business and strategy. We also explain our approach to sustainability and our commitments for future improvement Managing risk in delivering our strategy 58 Corporate responsibility 65 Governance Accounts Smiths Group plc Annual Report 2015 1 Strategic report Smiths Detection’s Lightweight Chemical Detector (LCD) is one of the most widely used devices to protect soldiers and emergency responders from chemical warfare agents or toxic substances. Easily held or clipped to a belt, the LCDs continually sample the air and the latest version features both audible and visual alarms. 2 Smiths Group plc Annual Report 2015 Strategic overview We explain who we are, where we operate, our business model and strategy, investment case and a summary of how we performed against our key performance indicators Bringing technology to life 4 Who we are 8 Our geographic reach 9 Our divisions 10 Strategic report – Strategic overview – Strategic report Strategic Chairman’s statement 12 Chief Executive’s statement 14 Our markets 17 Our business model 18 Our strategy and progress 20 The investment case 22 Operational review For the Group and each division, we review our markets and trends, key operational developments during the year and future outlook. We also review review – Operational report Strategic our financial performance Group 23 John Crane 24 Smiths Medical 30 Smiths Detection 36 Smiths Interconnect 42 Flex-Tek 48 Financial review 54 Litigation 57 and responsibility – Risks report Strategic Risks and responsibility We set out the key risks that may affect our business and strategy. We also explain our approach to sustainability and our commitments for future improvement Managing risk in delivering our strategy 58 Corporate responsibility 65 Governance Accounts Smiths Group plc Annual Report 2015 3 We bring technology to life to help to make the world safer, healthier and more productive. We transform laboratory science into advanced, hands–on technologies that solve our customers’ toughest challenges and make the world a safer, healthier and more productive place. Our products and services – often hidden from view – touch the lives of millions of people around the world every day. 4 Smiths Group plc Annual Report 2015 Making the world safer Strategic report – Strategic overview – Strategic report Strategic Strategic report – Operational review – Operational report Strategic Strategic report – Risks and responsibility – Risks report Strategic Governance Millions of air travellers around the world are protected every day by Smiths Detection equipment. Over 75,000 of our advanced X-ray scanners have been deployed around the world. In aviation security they detect and identify threat items in passenger bags, hold luggage and freight. Accounts Smiths Group plc Annual Report 2015 5 Making the world healthier Smiths Medical’s Gripper safety needles access implanted ports to draw blood or deliver medication, particularly in cancer and transplant patients. The safety needle of choice among clinicians, a Gripper is used on average every 3.6 seconds in hospitals and clinics in more than 80 countries. 6 Smiths Group plc Annual Report 2015 Making the world more productive Strategic report – Strategic overview – Strategic report Strategic Strategic report – Operational review – Operational report Strategic Strategic report – Risks and responsibility – Risks report Strategic Governance From extraction and transport to storage and refining, the world’s oil and gas industries rely on John Crane for vital equipment and support. Its mechanical seals, filtration systems and bearings, backed by a global service network, help ensure safe and efficient delivery of the energy that powers the modern world. Accounts Smiths Group plc Annual Report 2015 7 Who we are Smiths Group is a global technology company listed on the London Stock Exchange. Our vision is to establish Smiths Group as a world-leading engineering business. What we do Our markets Our structure We apply leading-edge technology to We serve a wide range of end markets – We employ over 23,000 people in more than design, manufacture and deliver innovative from healthcare, energy and petrochemicals 50 countries through our five divisions: John solutions that meet our customers’ needs. through to threat and contraband detection, Crane, Smiths Medical, Smiths Detection, Our products and services – often hidden telecommunications and equipment Smiths Interconnect and Flex-Tek. from view – touch the lives of millions of manufacture. Our customers range Our approach people
Recommended publications
  • Annex 1: Parker Review Survey Results As at 2 November 2020
    Annex 1: Parker Review survey results as at 2 November 2020 The data included in this table is a representation of the survey results as at 2 November 2020, which were self-declared by the FTSE 100 companies. As at March 2021, a further seven FTSE 100 companies have appointed directors from a minority ethnic group, effective in the early months of this year. These companies have been identified through an * in the table below. 3 3 4 4 2 2 Company Company 1 1 (source: BoardEx) Met Not Met Did Not Submit Data Respond Not Did Met Not Met Did Not Submit Data Respond Not Did 1 Admiral Group PLC a 27 Hargreaves Lansdown PLC a 2 Anglo American PLC a 28 Hikma Pharmaceuticals PLC a 3 Antofagasta PLC a 29 HSBC Holdings PLC a InterContinental Hotels 30 a 4 AstraZeneca PLC a Group PLC 5 Avast PLC a 31 Intermediate Capital Group PLC a 6 Aveva PLC a 32 Intertek Group PLC a 7 B&M European Value Retail S.A. a 33 J Sainsbury PLC a 8 Barclays PLC a 34 Johnson Matthey PLC a 9 Barratt Developments PLC a 35 Kingfisher PLC a 10 Berkeley Group Holdings PLC a 36 Legal & General Group PLC a 11 BHP Group PLC a 37 Lloyds Banking Group PLC a 12 BP PLC a 38 Melrose Industries PLC a 13 British American Tobacco PLC a 39 Mondi PLC a 14 British Land Company PLC a 40 National Grid PLC a 15 BT Group PLC a 41 NatWest Group PLC a 16 Bunzl PLC a 42 Ocado Group PLC a 17 Burberry Group PLC a 43 Pearson PLC a 18 Coca-Cola HBC AG a 44 Pennon Group PLC a 19 Compass Group PLC a 45 Phoenix Group Holdings PLC a 20 Diageo PLC a 46 Polymetal International PLC a 21 Experian PLC a 47
    [Show full text]
  • Constituents & Weights
    2 FTSE Russell Publications 19 August 2021 FTSE 100 Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 3i Group 0.59 UNITED GlaxoSmithKline 3.7 UNITED RELX 1.88 UNITED KINGDOM KINGDOM KINGDOM Admiral Group 0.35 UNITED Glencore 1.97 UNITED Rentokil Initial 0.49 UNITED KINGDOM KINGDOM KINGDOM Anglo American 1.86 UNITED Halma 0.54 UNITED Rightmove 0.29 UNITED KINGDOM KINGDOM KINGDOM Antofagasta 0.26 UNITED Hargreaves Lansdown 0.32 UNITED Rio Tinto 3.41 UNITED KINGDOM KINGDOM KINGDOM Ashtead Group 1.26 UNITED Hikma Pharmaceuticals 0.22 UNITED Rolls-Royce Holdings 0.39 UNITED KINGDOM KINGDOM KINGDOM Associated British Foods 0.41 UNITED HSBC Hldgs 4.5 UNITED Royal Dutch Shell A 3.13 UNITED KINGDOM KINGDOM KINGDOM AstraZeneca 6.02 UNITED Imperial Brands 0.77 UNITED Royal Dutch Shell B 2.74 UNITED KINGDOM KINGDOM KINGDOM Auto Trader Group 0.32 UNITED Informa 0.4 UNITED Royal Mail 0.28 UNITED KINGDOM KINGDOM KINGDOM Avast 0.14 UNITED InterContinental Hotels Group 0.46 UNITED Sage Group 0.39 UNITED KINGDOM KINGDOM KINGDOM Aveva Group 0.23 UNITED Intermediate Capital Group 0.31 UNITED Sainsbury (J) 0.24 UNITED KINGDOM KINGDOM KINGDOM Aviva 0.84 UNITED International Consolidated Airlines 0.34 UNITED Schroders 0.21 UNITED KINGDOM Group KINGDOM KINGDOM B&M European Value Retail 0.27 UNITED Intertek Group 0.47 UNITED Scottish Mortgage Inv Tst 1 UNITED KINGDOM KINGDOM KINGDOM BAE Systems 0.89 UNITED ITV 0.25 UNITED Segro 0.69 UNITED KINGDOM
    [Show full text]
  • Board of Directors
    Board of Directors 1. John McFarlane OBE 2. Tim O’Toole CBE 3. Chris Surch Chairman Chief Executive Group Finance Director Appointed to the Board: 2013 Appointed to the Board: 2009 Appointed to the Board: 2012 Skills and experience: He was appointed to the Skills and experience: He was appointed to Skills and experience: He has a strong track Board in December 2013 and became Chairman the Board in 2009 and became Chief Executive record of financial leadership as well as extensive in January 2014. John has a proven track record in 2010. Tim brings to the Board a wealth of operational, strategic and international experience. of implementing cultural transformation and driving international transport management experience Chris was previously Group Finance Director of through strategic change. He was formerly CEO gained over a number of years in the sector. Prior Shanks Group plc, also for a period of time serving of Australia and New Zealand Banking Group Ltd, to joining the Company, he was Managing Director, as their acting Chief Executive. Following an early Group Executive Director of Standard Chartered plc London Underground, having previously been at career with Price Waterhouse, he joined TI Group and Chairman of Aviva plc. He will step down as Transport for London, and prior to which he was plc in 1995. He held a number of senior roles there Chairman at the conclusion of the forthcoming President and Chief Executive of Consolidated and following the merger of TI Group plc with Annual General Meeting. Rail Corporation. Smiths Group plc he went on to hold further senior Other appointments: Chairman of Barclays plc Other appointments: He is a Non-Executive finance roles, latterly serving as Finance Director of and Barclays Bank plc, and a Non-Executive Director of CSX Corporation, a rail freight their Speciality Engineering division.
    [Show full text]
  • Diversified International Fund As of April 30, 2018
    Diversified International Fund As of April 30, 2018 SCHEDULE OF INVESTMENTS MARKET % TOTAL NET ISSUER SHARES VALUE ASSETS Australia CSL Ltd 814,527 $ 104,331,664 0.83% Macquarie Group Ltd 1,257,437 $ 102,403,171 0.81% Mirvac Group 31,695,172 $ 53,190,044 0.42% Treasury Wine Estates Ltd 2,867,805 $ 40,963,586 0.32% Dexus 5,413,746 $ 38,500,008 0.30% Total Australia $ 339,388,473 2.69% Austria Erste Group Bank AG 1,747,280 $ 85,444,781 0.68% Raiffeisen Bank International AG 1,820,658 $ 61,458,171 0.49% Total Austria $ 146,902,952 1.16% Brazil Vale SA 11,208,800 $ 155,596,011 1.23% Itausa - Investimentos Itau SA 24,445,471 $ 94,552,447 0.75% Banco do Brasil SA 8,072,700 $ 84,616,792 0.67% Ambev SA 8,524,800 $ 56,747,641 0.45% Hypera SA 4,186,014 $ 37,809,402 0.30% MRV Engenharia e Participacoes SA 5,609,500 $ 23,922,679 0.19% Petrobras Distribuidora SA 3,559,400 $ 23,493,140 0.19% Itausa - Investimentos Itau SA 591,015 $ 2,277,547 0.02% Total Brazil $ 479,015,659 3.79% Canada Brookfield Asset Management Inc 3,415,802 $ 135,387,020 1.07% Toronto-Dominion Bank/The 2,134,900 $ 119,901,584 0.95% Canadian National Railway Co 1,551,948 $ 119,869,686 0.95% Suncor Energy Inc 2,765,500 $ 105,756,494 0.84% Dollarama Inc 839,416 $ 96,706,581 0.77% Alimentation Couche-Tard Inc 2,195,346 $ 94,913,086 0.75% TransCanada Corp 2,122,306 $ 89,986,634 0.71% Bank of Montreal 1,101,600 $ 84,459,289 0.67% Canadian Natural Resources Ltd 2,005,800 $ 72,361,584 0.57% Bank of Nova Scotia/The 1,122,400 $ 68,990,076 0.55% Open Text Corp 968,800 $ 34,203,594 0.27% Total
    [Show full text]
  • FORWARD Annual Report and Accounts 2001 >EQUIPPED >Being Prepared Is Everything
    Smiths Group plc Annual report and accounts 2001 >FORWARD Annual report and accounts 2001 >EQUIPPED >Being prepared is everything. At Smiths we focus on the future. What will our customers want tomorrow? How can we exploit technology to provide enhanced solutions for their most demanding applications? How can we extend our capabilities to give them the service they need? We are constantly searching for ways to add value for our customers. This is how we generate profitable organic growth. >DISCOVERY >Discovery is about being always one step ahead. It is about meeting needs in ways that others haven’t yet thought of. It is about developing products that provide innovative solutions for the toughest applications. Through total commitment to research and development, Smiths seeks sustainable competitive advantage. >TEAMWORK >At Smiths we believe in teamwork. We work closely with our suppliers and customers to build productive partnerships and long-term relationships. Within the company, too, teamwork is essential. Not just working together day by day, but focusing everyone's efforts on maximum efficiency, productivity, flexibility and responsiveness. Through teamwork we seek to be a leader. >REACH >In a world where efficiency is paramount, customers want to deal with fewer, better suppliers. At Smiths we have the necessary size and diversity. We are global. Our products are wide-ranging. We have the reach to be our customers’ preferred supplier. 01 03 01 As a first-tier supplier working directly 03 We are a leading supplier of products used with prime manufacturers, we are during critical and intensive care procedures, delivering systems for front-line defence and for continuing care during recovery.
    [Show full text]
  • Evenlode Investment View January 2020
    Evenlode Investment View January 2020 In this month’s investment view, I’ll review 2019 for Evenlode Income and briefly discuss my thoughts on the outlook. I’ve also included a summary of the fourth quarter as an appendix for those interested. It’s been a relatively quiet start to 2020 so far, with Evenlode Income up +1.3% and the UK market +1.2%*. The full year results season is commencing with lots of company updates due over the next few weeks. I’ll discuss some key themes that we’re hearing from the corporate world in February’s investment view. From Pessimism to Optimism At the beginning of 2019, investor sentiment was quite negative with worries over rising interest rate rises, trade tariffs, the global economy and Brexit. This had caused a significant sell-off in most stock markets at the end of 2018 and was beginning to create a valuation environment that we felt was as interesting as it had been for three or four years. Since then sentiment has, quite sharply, swung towards optimism. Though the global economy did slow during the year, it’s just about muddled along, and perhaps most significantly for financial assets, monetary policy was eased. Towards the end of the year better news on US/China trade tariffs and more clarity on the UK’s political situation also helped. This meant 2019 ended up being a strong year for most global stock markets. A Long-Term Approach Evenlode Income returned 24.3% during the year compared to 19.2% for the FTSE All-Share.
    [Show full text]
  • Engineering Growth
    ANNUAL REPORT AND ACCOUNTS 2002 ENGINEERING GROWTH 02 SMITHS FOCUSES ON ENGINEERING GROWTH THROUGH INNOVATIVE PRODUCT DEVELOPMENT, TARGETED ACQUISITIONS AND CONTINUAL EFFICIENCY IMPROVEMENTS. CONTENTS 01 SUMMARY PERFORMANCE 2002 30 CONSOLIDATED PROFIT AND 04 CHAIRMAN’S STATEMENT LOSS ACCOUNT 05 CHIEF EXECUTIVE’S OPERATING REVIEW STATEMENT OF TOTAL RECOGNISED GAINS AND LOSSES 11 FINANCIAL REVIEW 31 BALANCE SHEETS 15 CORPORATE AND SOCIAL RESPONSIBILITY REVIEW 32 CASH-FLOW STATEMENT 18 BOARD OF DIRECTORS 33 NOTES TO THE ACCOUNTS 20 DIRECTORS’ REPORT 55 ACCOUNTING POLICIES 25 DIRECTORS’ EMOLUMENTS 56 FIVE YEAR REVIEW AND INTERESTS IBC FINANCIAL CALENDAR 29 STATEMENT OF DIRECTORS’ RESPONSIBILITIES INDEPENDENT AUDITORS’ REPORT SUMMARY PERFORMANCE 2002 2002 2001 CONTINUING ACTIVITIES Sales Profit Sales Profit £m £m £m £m Aerospace 1,346 191 1,301 209 Medical 480 97 452 93 Sealing Solutions 822 100 892 104 Industrial 422 64 487 93 Operating – continuing* 3,070 452 3,132 499 Interest – continuing (46) (58) Pre-tax profit – continuing* 406 441 EPS – continuing* 52.3p 56.4p * before goodwill amortisation and exceptionals 2002 2001 DISCONTINUED ACTIVITIES Sales Profit Sales Profit Operating – discontinued* 153 10 1,826 152 Interest – discontinued (11) (58) Pre-tax profit – discontinued* (1) 94 * before goodwill amortisation and exceptionals 2002 2001 CONTINUING AND DISCONTINUED ACTIVITIES Sales Profit Sales Profit Pre-tax* 3,223 405 4,958 535 Amortisation (51) (49) Exceptionals (68) (598) Pre-tax profit 286 (112) EPS – overall 34.4p (37.3p) * before
    [Show full text]
  • Annual Report 2011 (PDF)
    Johnson Matthey > TheJOHNSON group focuses MATTHEY on its IScore A skillsSPECIALITY in catalysis, CHEMICALS precious 2011 metals,COMPANY fine chemicalsAND A WORLD and process LEADER technology, IN ADVANCED developing ANNUAL REPORT & ACCOUNTS productsMATERIALS that enhanceTECHNOLOGY. the quality of life for millions of people around the world. The group has operations in over 5th Floor 25 Farringdon Street 30 countries and employs around 9,700 people. Johnson London EC4A 4AB Matthey’s operations are organised into three global United Kingdom Tel: +44 (0)20 7269 8400 divisions: Environmental Technologies, Precious Metal Fax: +44 (0)20 7269 8433 Products and Fine Chemicals. WHERE WE OPERATE Scandinavia UK USA / Canada Europe Asia Central America Africa Australia South America Johnson Matthey’s > TODAY, long term commitment to investment in research and development, as well Annual Report & 2011 Accounts as in new manufacturing technologies and production facilities enables the company to exploit the potential for growth in many of its key > www.matthey.com product areas. To view our online annual report CAUTIONARY STATEMENT GO ONLINE The Business Review and certain other sections of this annual report contain forward looking statements that are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which the group operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. Johnson Matthey > TheJOHNSON group focuses MATTHEY on its IScore A skillsSPECIALITY in catalysis, CHEMICALS precious 2011 metals,COMPANY fine chemicalsAND A WORLD and process LEADER technology, IN ADVANCED developing ANNUAL REPORT & ACCOUNTS productsMATERIALS that enhanceTECHNOLOGY.
    [Show full text]
  • Annual Report 2014 Smiths Group Plc 1851 1914 2014
    Annual Report 2014 Smiths Group plc 1851 1914 2014 Samuel Smith opens his first jewellery S. Smith & Sons floats on the London A world leader in advanced technologies, shop in south London Stock Exchange, only days before the Smiths today employs more than 23,000 First World War breaks out people in over 50 countries Smiths founded Smiths floats Founded in 1851 as a jewellery shop S. Smith & Sons floats on the in south London a year after the Great London Stock Exchange, days before Exhibition, Smiths opened its doors the outbreak of the First World War. during a period of enormous optimism In the supporting prospectus it and huge advances in technology. was clear that Smiths speedometers Establishing itself as a leader in precision and carburettors dominated the instruments over the following decades, domestic car markets. Smiths focus on leading-edge technology Already a substantial business, has remained constant throughout the head office employed over its history. 300 employees. 1914 1851 1912 1913 1904 The earliest speedometer Eyeing the potential of the motor car, Smiths is a pioneer in the development Purpose-built headquarters of speedometers and rapidly becomes Speedometer House, Great Portland the market leader Street, London, is specially built for Smiths Smiths opens for business Samuel Smith opens his first jewellery Sledge-meter aids South Pole success shop in south London A Smiths speedometer is adapted as a sledge-meter for Captain Scott’s epic South Pole expedition Celebrating 100 years as a listed company First synchronous
    [Show full text]
  • FMI International Fund Investor Class: FMIJX Institutional Class: FMIYX
    FMI International Fund Investor Class: FMIJX Institutional Class: FMIYX Quarter-End Positions 06/30/2021 Unaudited PERCENTAGE OF TOTAL NET SYMBOL SECURITY DESCRIPTION SHARES HELD PRICE MARKET VALUE ASSETS AKZA NA Akzo Nobel N.V. 570,000 123.82 70,577,742 1.9 090435 KS Amorepacific Corp. Preferred 825,000 78.22 64,530,520 1.7 ACGL Arch Capital Group Ltd. 900,000 38.94 35,046,000 0.9 BME LN B&M European Value Retail S.A. 24,450,000 7.94 194,104,678 5.2 BOL FP Bolloré 19,500,000 5.36 104,604,858 2.8 BKNG Booking Holdings Inc. 48,000 2188.09 105,028,320 2.8 BVI FP Bureau Veritas S.A. 2,360,000 31.66 74,725,693 2.0 CB Chubb Ltd. 510,000 158.94 81,059,400 2.2 1 HK CK Hutchison Holdings Ltd. 17,000,000 7.78 132,341,761 3.5 CNHI IM CNH Industrial N.V. 4,250,000 16.59 70,497,464 1.9 DBS SP DBS Group Holdings Ltd. 3,300,000 22.25 73,416,121 2.0 DKSH SW DKSH Holding AG 1,265,000 76.61 96,909,462 2.6 EXPD Expeditors International of Washington Inc. 370,000 126.60 46,842,000 1.3 FERG LN Ferguson PLC 1,410,000 139.13 196,169,168 5.3 FME GR Fresenius Medical Care AG & Co. KGaA 1,350,000 83.10 112,179,690 3.0 GRG LN Greggs PLC 1,151,000 35.99 41,430,071 1.1 HEN GR Henkel AG & Co.
    [Show full text]
  • Corporate Responsibility Report Year Ended 31July 2008 Protecting and Enhancing Value
    Corporate responsibility report Year ended 31July 2008 Protecting and enhancing value 2 Smiths Group plc Corporate responsibility report, year ended 31 July 2008 3 Smiths Group plc Corporate responsibility report, year ended 31 July 2008 Smiths Group: A global business Smiths Group major manufacturing and service locations by division Smiths Detection John Crane Smiths Medical Smiths Interconnect Flex-Tek Flex-Tek Piloting a new EHS programme in Tennessee, USA Flex-Tek business Tutco, based in Cookeville, Tennessee, is piloting a new Environment Health and Safety programme in a drive to become OHSAS 18001 certified. Smiths Detection The programme seeks Manufacturing expansion to eliminate injuries in Maryland, USA and reduce hazards in Smiths Detection has the workplace. The results expanded its are already encouraging as manufacturing capacity at the number of recordable its Edgewood site by 50% injuries has been reduced to fulfil increased demand to zero and recordable from the US Department incidents have reduced by of Defense Chemical 25%, while operating costs Biological Protection at the facility have also Shelters (CBPS) been cut. Smiths Medical Smiths Interconnect John Crane programme. CBPS Automation in New Opening up in Tunisia Servicing customers provides contamination Hampshire, USA Smiths Interconnect in Saudi Arabia free, environmentally Each year around 150 recently opened a new John Crane is expanding controlled working areas million safety needles are low-cost manufacturing its global service and for medical and combat produced at our Smiths facility in Tunisia to serve support network. In services personnel in Medical manufacturing its European customers. addition to opening new operational circumstances. facility in Keene.
    [Show full text]
  • 2021 Virtual Market Update
    Virtual Market Update May 2021 COVID-19 six months on • Total cases 10 December 2020 – 68.9m • Total deaths 10 December 2020 – 1.57m • Today… Source: Johns Hopkins University Virus Tracker 2 2021 – Recovery Summary • The vaccine v virus race continues, with new variants the emerging contender • The recovery in the second half of 2021 is likely to be very strong, but unevenly distributed • Leaders in vaccination to be leaders in recovery • Central banks have a herculean task in balancing support with growth and inflation • Long term real return (above inflation) targets become more important • Ongoing cyclical catch up for last year’s losers • Structural shift to sustainable investing remains a key theme 4 Vaccine vs Virus • More than 1.45 billion doses have been administered across 175 countries • The latest rate was roughly 23.7 million doses per day • But does the virus care? Source: Bloomberg Virus Tracker 5 Vaccine vs Virus • Distribution is uneven globally • Wealth and politics have so far dictated the success or otherwise of vaccine distribution Source: Bloomberg Virus Tracker 6 Vaccine vs Virus % of population with at least one dose Has the delay pushed back the recovery? Source: Bloomberg Virus Tracker 7 Major Markets – Pandemic Recovery Source: Morningstar. UK, US, Japan, Europe and Chinese major indices, 18/02/2020-16/05/2021 8 Major Markets – Pandemic Recovery Source: Morningstar. UK, US, Japan, Europe and Chinese major indices, 01/01/2021-16/05/2021 9 China slowdown? Source: Morningstar 10 Asian Epicentre • Asia-Pacific stocks are underperforming global peers as virus cases surge Source: Bloomberg 11 Global Rebound • IMF predicts growth in 2021 will be the most since at least 1980 Source: International Monetary Fund 12 Recovery Leaders – US • Date of inception – 17 May 1792 • Size - $49 Trillion • No.
    [Show full text]